Clinical Trials - ALZN

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06921590A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult SubjectsACTIVE_NOT_RECRUITINGPHASE12025-05-092025-122025-11
NCT05834296Study in Subjects With Mild-to-Moderate Alzheimer's DementiaACTIVE_NOT_RECRUITINGPHASE1, PHASE22023-07-052028-03-032028-03-03
NCT05363293Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult SubjectsCOMPLETEDPHASE1, PHASE22022-05-042023-05-152023-04-14